Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

34.26 -0.01 (-0.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

Why Shares of Viking Therapeutics Skyrocketed This Week ↗

March 30, 2023

The clinical-stage stock nearly doubled in price.

Via The Motley Fool

RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

March 30, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...

Via Benzinga

Tesla, RH, Rumble, Stem, Viking Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

March 29, 2023

Via Benzinga

BTIG Maintains Buy Rating for Viking Therapeutics: Here's What You Need To Know ↗

March 29, 2023

Via Benzinga

The Government Move That Could Drive Obesity Drugs — And Lilly, Novo Shares ↗

March 29, 2023

The decision from the WHO could further bolster use of Novo's Saxenda and Wegovy.

Via Investor's Business Daily

Airbnb To Rally Around 59%? Here Are 10 Other Analyst Forecasts For Wednesday ↗

March 29, 2023

Keybanc raised the price target for Intuit Inc. (NASDAQ: INTU) from $450 to $475. Keybanc analyst Josh Beck maintained an Overweight rating. Intuit shares fell 1.8% to close at $419.33 on Tuesday.

Via Benzinga

Viking Therapeutics Steps Into The Obesity Ring — And Catapults 63% ↗

March 28, 2023

The company is taking on rivals Novo Nordisk, Eli Lilly and Amgen.

Via Investor's Business Daily

4 Analysts Have This to Say About Viking Therapeutics ↗

March 17, 2023

Via Benzinga

Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run ↗

March 29, 2023

Viking Therapeutics stock might in the midst of a historic run.

Via The Motley Fool

Should You Buy Viking Therapeutics Stock After It Skyrocketed Over 60%? ↗

March 29, 2023

Viking could have a strong rival to Novo Nordisk's Wegovy and Ozempic and Lilly's Mounjaro in the making.

Via The Motley Fool

Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says ↗

March 28, 2023

Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735.

Via Benzinga

Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results ↗

March 28, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

2 Surging Healthcare Stocks That Are Still Worth Buying ↗

February 23, 2023

These two NASH drugmakers have a lot of room to run.

Via The Motley Fool

Viking Therapeutics's Earnings: A Preview ↗

February 07, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Viking Therapeutics Inc. (NASDAQ: VKTX) Records 52-Week High Tuesday Morning

March 28, 2023

Via Investor Brand Network

Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data

March 28, 2023

Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP

Via MarketBeat

Dow Rises 50 Points; Harmony Biosciences Shares Plunge ↗

March 28, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also...

Via Benzinga

Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly ↗

March 28, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.01% to 32,436.22 while the NASDAQ fell...

Via Benzinga

Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today? ↗

March 28, 2023

Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 28, 2023

Via Benzinga

Why Is Viking Therapeutics (VKTX) Stock Up 38% Today? ↗

March 28, 2023

Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735.

Via InvestorPlace

Why Viking Therapeutics Stock Is Soaring Tuesday ↗

March 28, 2023

Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company reported results from its Phase 1 trial of VK2735 for the potential treatment of

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Via InvestorPlace

Is Viking Therapeutics a Smart Buy on the Dip? ↗

March 27, 2023

The stock recently fell around 25% for reasons that had nothing to do with its lead program.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 21, 2023

Via Benzinga

Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 21, 2023

Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023 ↗

March 17, 2023

Via Benzinga

Analyzing Viking Therapeutics's Short Interest ↗

January 03, 2023

Viking Therapeutics's (NASDAQ:VKTX) short percent of float has risen 7.17% since its last report. The company recently reported that it has 1.89 million shares sold short, which is 2.54% of all regular...

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

All News about Viking Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today